Mesoblast Ltd Files 6-K with ASX Announcement
Ticker: MEOBF · Form: 6-K · Filed: Sep 29, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Sep 29, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, announcement, regulatory-update
TL;DR
MESO filed a 6-K on 9/29, referencing an ASX announcement from 9/26. Check for updates.
AI Summary
Mesoblast Limited filed a Form 6-K on September 29, 2025, reporting a new release announcement made on September 26, 2025, to the Australian Securities Exchange. The filing is for the month of September 2025 and Mesoblast Limited is incorporated in Australia. The company's CEO is Silviu Itescu.
Why It Matters
This filing indicates Mesoblast Limited is providing an update or making an announcement to the market via the Australian Securities Exchange, which could contain material information for investors.
Risk Assessment
Risk Level: medium — Form 6-K filings often contain updates or announcements that can impact a company's stock price, requiring careful review.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- September 26, 2025 (date) — Date of ASX announcement
- September 29, 2025 (date) — Filing date of Form 6-K
- Australian Securities Exchange (company) — Exchange where announcement was filed
FAQ
What is the subject of the new release announcement filed by Mesoblast Limited on September 26, 2025?
The provided text does not specify the subject of the new release announcement, only that it was filed with the Australian Securities Exchange and is attached as Exhibit 99.1 to the 6-K.
What is Mesoblast Limited's jurisdiction of incorporation?
Mesoblast Limited is incorporated in Australia.
Who is the Chief Executive Officer of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
What is the SEC file number for Mesoblast Limited?
The SEC file number for Mesoblast Limited is 001-37626.
Is Mesoblast Limited required to file Form 20-F or Form 40-F annually?
Mesoblast Limited indicates it files annual reports under Form 20-F.
Filing Stats: 212 words · 1 min read · ~1 pages · Grade level 17.3 · Accepted 2025-09-29 07:22:09
Filing Documents
- a2025-09x29productsnotsubj.htm (6-K) — 15KB
- exhibit991.htm (EX-99.1) — 8KB
- exhibit991001.jpg (GRAPHIC) — 249KB
- exhibit991002.jpg (GRAPHIC) — 221KB
- 0001345099-25-000079.txt ( ) — 672KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated September 29, 2025 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated September 26, 2025.